Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI143931 R01AI125365
NIAID NIH HHS
Grant: R01 AI143931
NIAID NIH HHS
Grant: R01 AI125365
National Institutes of Health
Grant: 5R01AI143931-02
Non-immunosuppressive Sanglifehrin Analogs as Therapeutic Agents for Viral Hepatitis-induced Liver Damage Development
National Institutes of Health
Grant: 5R01AI125365-02
Analyses of the Antiviral and Antifibrotic Mechanisms of Action of NS5A and Cyclophilin Inhibitors
FWCI
1.25
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals